We are live on ! Find out more
SCV

Sands Capital Ventures Portfolio holdings

AUM $614M
1-Year Est. Return 19.92%
This Fund
S&P 500
This Quarter Est. Return
-13.11%
1 Year Est. Return
+19.92%
3 Year Est. Return
+166.76%
5 Year Est. Return
+157.76%
10 Year Est. Return
–
AUM
$675M
AUM Growth
+$11.5M
Cap. Flow
+$133M
Cap. Flow %
19.78%
Top 10 Hldgs %
95.47%
Holding
16
New
3
Increased
–
Reduced
2
Closed
–

Top Buys

Rank Stock Value
1
NU icon
Nu Holdings
NU
+$89.7M
2
IOT icon
Samsara
IOT
+$8.49M

Top Sells

Rank Stock Value
1
SNOW icon
Snowflake
SNOW
+$35.5M
2
DASH icon
DoorDash
DASH
+$5.45M

Sector Composition

Rank Sector Weight
1 Technology 36.5%
2 Healthcare 26.22%
3 Consumer Discretionary 13.27%
4 Financials 12.7%
5 Miscellaneous 11.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PATH icon
1
UiPath
PATH
$6.42B
$164M 24.37%
3,811,779
– –
DASH icon
2
DoorDash
DASH
$81.1B
$89.6M 13.27%
601,454
-28,763
-5% -$5.45M
NU icon
3
Nu Holdings
NU
$59.7B
$85.7M 12.7%
+9,136,835
New +$89.7M
DICE
4
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
$79.7M 11.81%
3,148,970
– –
SNOW icon
5
Snowflake
SNOW
$117B
$72.7M 10.78%
214,621
-101,955
-32% -$35.5M
KRTX
6
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$35.1M 5.2%
267,895
– –
ABOS icon
7
Acumen Pharmaceuticals
ABOS
$163M
$23.1M 3.42%
3,417,075
– –
IOT icon
8
Samsara
IOT
$22.2B
$9.16M 1.36%
+326,000
New +$8.49M
MASS icon
9
908 Devices
MASS
$490M
$8.45M 1.25%
326,427
– –
TSHA icon
10
Taysha Gene Therapies
TSHA
$1.63B
$8.45M 1.25%
724,873
– –
CADL icon
11
Candel Therapeutics
CADL
$833M
$6.35M 0.94%
811,737
– –
RGEN icon
12
Repligen
RGEN
$11B
$5.97M 0.89%
22,544
– –
TARS icon
13
Tarsus Pharmaceuticals
TARS
$3.59B
$5.85M 0.87%
260,000
– –
SPRB
14
Spruce Biosciences
SPRB
$136M
$3.51M 0.52%
10,493
– –
ABSI icon
15
Absci
ABSI
$1.74B
$474K 0.07%
57,804
– –

Similar funds

T2I
Turim 21 Investimentos Rio De Janeiro, Brazil $613M AUM 14.25% 1-Year Est. Return
VAG
VisionPoint Advisory Group Dallas, Texas $613M AUM 30.37% 1-Year Est. Return
MKA
M. Kulyk & Associates Decatur, Georgia $613M AUM 22.75% 1-Year Est. Return
CSIA
Conrad Siegel Investment Advisors Harrisburg, Pennsylvania $615M AUM 21.19% 1-Year Est. Return
ATFA
All Terrain Financial Advisors Coon Rapids, Minnesota $615M AUM 30.42% 1-Year Est. Return
AA
Aire Advisors Beverly Hills, California $615M AUM 25.07% 1-Year Est. Return
FWM
Fonville Wealth Management Richmond, Virginia $612M AUM 18.82% 1-Year Est. Return
FSA
Financial Security Advisor Virginia Beach, Virginia $615M AUM 26.08% 1-Year Est. Return

Sands Capital Ventures's Q4 2021 Portfolio in Review

As of Q4 2021, Sands Capital Ventures held 16 positions worth $675M, up 1.7% from $663M the previous quarter. Its ten largest holdings account for 95% of the portfolio.

Sands Capital Ventures deployed $133M of net new capital in Q4 2021, opening 3 new positions. Its largest new stake was Nu Holdings: 9,136,835 shares worth $85.7M.

By sector, the portfolio is most concentrated in Technology at 37% of assets, down from 45% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Snowflake, an estimated $35.5M trimmed.

  • Sands Capital Ventures's largest Q4 2021 buy was Nu Holdings: 9,136,835 shares worth $85.7M.
  • Sands Capital Ventures's biggest Q4 2021 reduction was Snowflake, cutting an estimated $35.5M.
  • Sands Capital Ventures's ten largest holdings make up 95% of its $675M portfolio in Q4 2021.
  • Sands Capital Ventures opened 3 new positions and closed 0 in Q4 2021.
  • Sands Capital Ventures's portfolio value rose 1.7% quarter-over-quarter to $675M.

Based on Sands Capital Ventures's 13F filing for Q4 2021, filed 21 Jan 2022.